261711-19-7

Basic information

• Product Name: 2-bromo-1-ethyl-4-fluorobenzene
• Synonyms: 2-bromo-1-ethyl-4-fluorobenzene
• CAS NO: 261711-19-7
• Molecular Weight: 203.054
• Mol File: 261711-19-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-bromo-1-ethyl-4-fluorobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-1-ethyl-4-fluorobenzene(261711-19-7)
• EPA Substance Registry System: 2-bromo-1-ethyl-4-fluorobenzene(261711-19-7)

Safety Data

• Hazardous Substances Data: 261711-19-7(Hazardous Substances Data)

Upstream product

• 261711-20-0 1-(2-bromo-4-fluorophenyl)ethan-1-ol 
• 1221684-51-0 2-bromo-4-fluoro-1-vinylbenzene 
• 59142-68-6 2-bromo-4-fluorobenzaldehyde 
• 1006-39-9 1-(2-bromo-4-fluorophenyl)ethanone 

Downstream Products

• 1241898-87-2 tert-butyl 4-[(2-ethyl-5-fluorophenyl)carbonyl]piperidine-1-carboxylate 
• 1241898-88-3 (2-ethyl-5-fluorophenyl)(piperidin-4-yl)methanone hydrochloride 
• 1241898-89-4 tert-butyl [5-(3-{4-[(2-ethyl-5-fluorophenyl)carbonyl]piperidin-1-yl}-4,5-dihydroisoxazol-5-yl)-2H-tetrazol-2-yl]-acetate 
• 1241898-90-7 tert-butyl [5-(3-{4-[(2-ethyl-5-fluorophenyl)carbonyl]piperidin-1-yl}isoxazol-5-yl)-2H-tetrazol-2-yl]acetate 
• 1241896-62-7 [5-(3-{4-[(2-ethyl-5-fluorophenyl)carbonyl]piperidin-1-yl}isoxazol-5-yl)-2H-tetrazol-2-yl]acetic acid 
• 2109805-55-0 4-bromo-5-ethyl-1H-indazole 

Relevant articles and documents

QUINOXALINE DERIVATIVES

The present invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.

HETEROCYCLIC DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE

Heterocyclic compounds of structural formula (I), or a pharmaceutically acceptable salt thereof, wherein W is a R1— substituted heteroaryl, R1 is an heteroaryl ring substituted with an ester or carboxylic acid containing radical, X-T is N—CR5R6, C═CR5 or CR13—CR5R6, Y is a bond or —C(O)—, a and b represent an integer selected from 1 to 4, and Ar is an optionally substituted phenyl or naphtyl, are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD) The heterocyclic compounds are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, atherosclerosis, obesity, diabetes, neurological disease, Metabolic Syndrome, insulin resistance, cancer, liver steatosis, and non-alcoholic steatohepatitis.

HIV protease inhibitors

The present invention relates to novel dihydropyrones with tethered heterocycles having improved pharmacologic properties which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The dihydropyrones are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of the dihydropyrones and intermediates useful in the preparation of the final compounds.